COCP vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW
Should you be buying Cocrystal Pharma stock or one of its competitors? The main competitors of Cocrystal Pharma include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.
Cocrystal Pharma vs. Its Competitors
180 Life Sciences (NASDAQ:ATNFW) and Cocrystal Pharma (NASDAQ:COCP) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.
In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.87 beat Cocrystal Pharma's score of 0.94 indicating that 180 Life Sciences is being referred to more favorably in the media.
6.7% of Cocrystal Pharma shares are held by institutional investors. 28.1% of Cocrystal Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
180 Life Sciences' return on equity of 0.00% beat Cocrystal Pharma's return on equity.
Cocrystal Pharma has a consensus price target of $6.00, suggesting a potential upside of 302.68%. Given Cocrystal Pharma's stronger consensus rating and higher possible upside, analysts clearly believe Cocrystal Pharma is more favorable than 180 Life Sciences.
Summary
Cocrystal Pharma beats 180 Life Sciences on 5 of the 8 factors compared between the two stocks.
Get Cocrystal Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding COCP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cocrystal Pharma Competitors List
Related Companies and Tools
This page (NASDAQ:COCP) was last updated on 6/30/2025 by MarketBeat.com Staff
